Maria João Gomes
Maria João Gomes
BIAL
E-mail confirmado em bial.com
Título
Citado por
Citado por
Ano
Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies
MJ Gomes, S Martins, D Ferreira, MA Segundo, S Reis
International Journal of Nanomedicine 9 (1), 1231-1242, 2014
832014
Thiolation and cell-penetrating peptide surface functionalization of porous silicon nanoparticles for oral delivery of insulin
N Shrestha, F Araújo, MA Shahbazi, E Mäkilä, MJ Gomes, ...
Advanced Functional Materials 26 (20), 3405-3416, 2016
642016
Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system
MJ Gomes, J das Neves, B Sarmento
International Journal of Nanomedicine 9 (1), 1757-1769, 2014
552014
Delivery of siRNA silencing P-gp in peptide-functionalized nanoparticles causes efflux modulation at blood-brain barrier
MJ Gomes, PJ Kennedy, S Martins, B Sarmento
Nanomedicine (London) 12 (12), 2017
382017
siRNA as a tool to improve the treatment of brain diseases: mechanism, targets and delivery
MJ Gomes, S Martins, B Sarmento
Ageing Research Reviews 21, 43-54, 2015
362015
Tailoring lipid and polymeric nanoparticles as siRNA carriers towards the blood-brain barrier – from targeting to safe administration
MJ Gomes, C Fernandes, S Martins, F Borges, B Sarmento
Journal of Neuroimmune Pharmacology 12 (1), 107-119, 2017
332017
In vivo dual-delivery of glucagon like peptide -1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy
F Araújo, N Shrestha, MJ Gomes, B Herranz-Blanco, D Liu, JJ Hirvonen, ...
Nanoscale 8 (20), 10706-10713, 2016
312016
Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model
N Shrestha, F Araújo, MA Shahbazi, E Mäkilä, MJ Gomes, M Airavaara, ...
Journal of Controlled Release 232, 113-119, 2016
292016
Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy
C Martins, F Araújo, MJ Gomes, C Fernandes, R Nunes, W Li, HA Santos, ...
European Journal of Pharmaceutics and Biopharmaceutics 138, 111-124, 2019
252019
Development of a PEGylated-based platform for efficient delivery of dietary antioxidants across the blood–brain barrier
C Fernandes, M Pinto, C Martins, MJ Gomes, B Sarmento, PJ Oliveira, ...
Bioconjugate chemistry 29 (5), 1677-1689, 2018
122018
A new approach for a blood-brain barrier model based on phospholipid vesicles: membrane development and siRNA-loaded nanoparticles permeability
MJ Gomes, J Dreier, J Brewer, S Martins, M Brandl, B Sarmento
Journal of Membrane Science 503, 8-15, 2016
122016
Cell-based in vitro models for studying blood-brain barrier (BBB) permeability
MJ Gomes, B Mendes, S Martins, B Sarmento
Concepts and models for drug permeability studies: cell and tissue based in …, 2016
92016
Nanoparticle functionalization for brain targeting drug delivery and diagnostic
MJ Gomes, B Mendes, S Martins, B Sarmento
Handbook of nanoparticles: synthesis, functionalization and surface …, 2016
32016
Modulation of drug efflux at the blood-brain barrier through targeted siRNA delivery via nanoparticles
MJBT Gomes
12017
Lipid nanoparticles for topical and transdermal application for alopecia treatment
MJ Gomes
Faculty of Engineering, University of Porto, Portugal, 2013
12013
Multifunctional tailorable composite system as a dual peptide-drug delivery system
F Araújo, N Shrestha, MJ Gomes, D Liu, B Herranz-Blanco, J Hirvonen, ...
Nanoparticles developed as siRNA carriers towards the blood-brain barrier: from targeting to safe administration
MJ Gomes, C Fernandes, S Martins, F Borges, B Sarmento
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–17